Winton Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-103,900
| Closed | -$8.72M | – | 1046 |
|
|
2025
Q3 | $8.72M | Buy |
103,900
+56,046
| +117% | +$4.62M | 0.33% | 72 |
|
|
2025
Q2 | $3.79M | Buy |
+47,854
| New | +$3.8M | 0.19% | 141 |
|
|
2024
Q4 | – | Sell |
-38,049
| Closed | -$4.32M | – | 723 |
|
|
2024
Q3 | $4.32M | Buy |
38,049
+11,135
| +41% | +$1.32M | 0.3% | 89 |
|
|
2024
Q2 | $3.33M | Buy |
26,914
+13,164
| +96% | +$1.7M | 0.23% | 87 |
|
|
2024
Q1 | $1.81M | Buy |
13,750
+1,855
| +16% | +$229K | 0.13% | 128 |
|
|
2023
Q4 | $1.3M | Buy |
+11,895
| New | +$1.23M | 0.09% | 151 |
|
|
2023
Q2 | – | Sell |
-29,512
| Closed | -$3.14M | – | 992 |
|
|
2023
Q1 | $3.14M | Sell |
29,512
-23,147
| -44% | -$2.5M | 0.19% | 106 |
|
|
2022
Q4 | $5.84M | Buy |
52,659
+2,787
| +6% | +$285K | 0.38% | 25 |
|
|
2022
Q3 | $4.29M | Sell |
49,872
-8,252
| -14% | -$737K | 0.28% | 60 |
|
|
2022
Q2 | $5.3M | Buy |
58,124
+31,313
| +117% | +$2.78M | 0.28% | 64 |
|
|
2022
Q1 | $2.2M | Buy |
+26,811
| New | +$2.11M | 0.12% | 230 |
|
|
2021
Q4 | – | Sell |
-12,028
| Closed | -$903K | – | 1261 |
|
|
2021
Q3 | $903K | Buy |
12,028
+5,488
| +84% | +$417K | 0.05% | 559 |
|
|
2021
Q2 | $509K | Sell |
6,540
-13,983
| -68% | -$1.04M | 0.03% | 912 |
|
|
2021
Q1 | $1.51M | Buy |
20,523
+7,129
| +53% | +$526K | 0.09% | 255 |
|
|
2020
Q4 | $1.04M | Sell |
13,394
-21,280
| -61% | -$1.63M | 0.08% | 390 |
|
|
2020
Q3 | $2.74M | Sell |
34,674
-47,997
| -58% | -$3.76M | 0.09% | 379 |
|
|
2020
Q2 | $6.1M | Buy |
+82,671
| New | +$6.22M | 0.16% | 147 |
|
|
2019
Q4 | – | Sell |
-3,083
| Closed | -$248K | – | 1697 |
|
|
2019
Q3 | $248K | Sell |
3,083
-1,643
| -35% | -$132K | ﹤0.01% | 1337 |
|
|
2019
Q2 | $378K | Sell |
4,726
-358
| -7% | -$27.4K | 0.01% | 788 |
|
|
2019
Q1 | $403K | Sell |
5,084
-71,400
| -93% | -$5.34M | 0.01% | 672 |
|
|
2018
Q4 | $5.58M | Buy |
+76,484
| New | +$5.4M | 0.12% | 260 |
|
|
2018
Q2 | – | Sell |
-10,813
| Closed | -$562K | – | 1112 |
|
|
2018
Q1 | $562K | Sell |
10,813
-5,946
| -35% | -$321K | 0.02% | 719 |
|
|
2017
Q4 | $900K | Sell |
16,759
-1,875
| -10% | -$104K | 0.03% | 418 |
|
|
2017
Q3 | $1.14M | Sell |
18,634
-28,235
| -60% | -$1.71M | 0.04% | 393 |
|
|
2017
Q2 | $2.87M | Buy |
46,869
+42,517
| +977% | +$2.59M | 0.08% | 231 |
|
|
2017
Q1 | $264K | Buy |
4,352
+342
| +9% | +$20.7K | 0.01% | 422 |
|
|
2016
Q4 | $225K | Sell |
4,010
-88,320
| -96% | -$5.17M | 0.01% | 434 |
|
|
2016
Q3 | $5.5M | Sell |
92,330
-51,227
| -36% | -$3M | 0.09% | 231 |
|
|
2016
Q2 | $7.89M | Sell |
143,557
-297,347
| -67% | -$15.8M | 0.13% | 208 |
|
|
2016
Q1 | $22.3M | Sell |
440,904
-47,451
| -10% | -$2.32M | 0.24% | 166 |
|
|
2015
Q4 | $24.6M | Buy |
488,355
+24,579
| +5% | +$1.24M | 0.22% | 178 |
|
|
2015
Q3 | $21.9M | Sell |
463,776
-186,049
| -29% | -$9.88M | 0.17% | 222 |
|
|
2015
Q2 | $35.3M | Sell |
649,825
-385,465
| -37% | -$21.6M | 0.32% | 116 |
|
|
2015
Q1 | $56.8M | Buy |
1,035,290
+598,316
| +137% | +$33.9M | 0.45% | 67 |
|
|
2014
Q4 | $23.7M | Sell |
436,974
-174,230
| -29% | -$9.71M | 0.29% | 129 |
|
|
2014
Q3 | $34.6M | Buy |
611,204
+29,803
| +5% | +$1.67M | 0.25% | 168 |
|
|
2014
Q2 | $32.1M | Buy |
+581,401
| New | +$31.7M | 0.22% | 194 |
|
Other funds holding MRK
Winton Group's MRK Position: Q4 2025 in Review
Winton Group sold out of Merck (MRK) in Q4 2025, closing a stake of 103,900 shares — an estimated $8.72M sold.
Winton Group first reported a position in MRK in Q2 2014 and held it in 37 quarters. The position peaked at $56.8M in Q1 2015. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Winton Group reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Winton Group sold 103,900 Merck shares in Q4 2025, an estimated $8.72M.
- Winton Group first reported a position in Merck in Q2 2014 and held it in 37 quarters.
- Winton Group's Merck position peaked at $56.8M in Q1 2015.
- 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.